Sabrina A. Assoumou, MD, MPH
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Infectious Diseases

MD, University of Rochester School of Medicine & Dentistry
MPH, Harvard School of Public Health




Sabrina A. Assoumou, MD MPH, is Assistant Professor of Medicine at Boston University School of Medicine and an attending physician in the section of Infectious Diseases at Boston Medical Center. She is a clinician-investigator who cares for human immunodeficiency virus (HIV)-infected patients at the BUSM/BMC’s Centers for Infectious Diseases. Her research focuses on medical complications of substance use including HIV and Hepatitis C virus (HCV). She is also interested in models of care and on improving the continuum of care for individuals with HIV and/or HCV. She is currently the Principal Investigator on an NIH K23 Mentored Career Development Award to improve linkage to care after testing for HIV and HCV at a drug detoxification center.

Dr. Assoumou graduated magna cum laude from Williams College and obtained her medical degree from the University of Rochester School of Medicine and Dentistry. She then completed a combined Internal Medicine/Pediatrics residency at Brown University and an Infectious Diseases Fellowship at Harvard University’s Beth Israel Deaconess Medical Center where she was awarded the Finland Award for Research Excellence. She also earned a Masters of Public Health at the Harvard T.H. Chan School of Public Health.



Engaging Young People who Inject Drugs into HCV and HIV Care
05/01/2018 - 04/30/2023 (PI)
NIH-NIDA
1K23DA044085-01A1

Mentoring Early-Career Scientists for Drug Abuse Research Careers
05/01/2016 - 04/30/2018 (PI)
The Regents of the University of California NIH-NIDA



Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Assoumou SA, Tasillo A, Vellozzi C, Yazdi GE, Wang J, Nolen S, Hagan L, Thompson W, Randall LM, Strick L, Salomon JA, Linas BP. Cost-effectiveness and budgetary impact of HCV testing, treatment and linkage to care in U.S. prisons. Clin Infect Dis. 2019 May 16.View Related Profiles. PMID: 31095676.
     
  2. Childs E, Assoumou SA, Biello KB, Biancarelli DL, Drainoni ML, Edeza A, Salhaney P, Mimiaga MJ, Bazzi AR. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduct J. 2019 Feb 11; 16(1):14.View Related Profiles. PMID: 30744628; DOI: 10.1186/s12954-019-0286-6;.
     
  3. Assoumou SA, Wang J, Tasillo A, Eftekhari Yazdi G, Tsui JI, Strick L, Linas BP. Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016. Am J Prev Med. 2019 Jan; 56(1):8-16.View Related Profiles. PMID: 30467088.
     
  4. Assoumou SA, Tasillo A, Leff JA, Schackman BR, Drainoni ML, Horsburgh CR, Barry MA, Regis C, Kim AY, Marshall A, Saxena S, Smith PC, Linas BP. Cost-Effectiveness of One-Time Hepatitis C Screening Strategies Among Adolescents and Young Adults in Primary Care Settings. Clin Infect Dis. 2018 Jan 18; 66(3):376-384.View Related Profiles. PMID: 29020317.
     
  5. Assoumou SA, Huang W, Young K, Horsburgh CR, Linas BP. Real-world Outcomes of Hepatitis C Treatment during the Interferon-free Era at an Urban Safety-net Hospital. J Health Care Poor Underserved. 2017; 28(4):1333-1344.View Related Profiles. PMID: 29176099.
     
  6. Linas BP, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. Cost Effectiveness and Cost Containment in the Era of Interferon-Free Therapies to Treat Hepatitis C Virus Genotype 1. Open Forum Infect Dis. 2017; 4(1):ofw266.View Related Profiles. PMID: 28480259.
     
  7. Young KL, Huang W, Horsburgh CR, Linas BP, Assoumou SA. Eighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmission. J Viral Hepat. 2016 Apr; 23(4):274-81.View Related Profiles. PMID: 26572798; DOI: 10.1111/jvh.12489;.
     
  8. Linas BP, Barter DM, Morgan JR, Pho MT, Leff JA, Schackman BR, Horsburgh CR, Assoumou SA, Salomon JA, Weinstein MC, Freedberg KA, Kim AY. The cost-effectiveness of sofosbuvir-based regimens for treatment of hepatitis C virus genotype 2 or 3 infection. Ann Intern Med. 2015 May 5; 162(9):619-29.View Related Profiles. PMID: 25820703; PMCID: PMC4420667; DOI: 10.7326/M14-1313;.
     
  9. Linas BP, Barter DM, Leff JA, Assoumou SA, Salomon JA, Weinstein MC, Kim AY, Schackman BR. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One. 2014; 9(5):e97317.View Related Profiles. PMID: 24842841; PMCID: PMC4026319; DOI: 10.1371/journal.pone.0097317;.
     
  10. Assoumou SA, Huang W, Horsburgh CR, Drainoni ML, Linas BP. Relationship between hepatitis C clinical testing site and linkage to care. Open Forum Infect Dis. 2014 Mar; 1(1):ofu009.View Related Profiles. PMID: 25734083; DOI: 10.1093/ofid/ofu009;.
     
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 7 distinct years, with a maximum of 4 publications in 2014

YearPublications
20132
20144
20152
20161
20171
20182
20192
Contact for Mentoring:

771 Albany St
Boston MA 02118
Google Map


Assoumou's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department